3.10Open3.10Pre Close0 Volume6 Open Interest7.50Strike Price0.00Turnover148.87%IV-9.18%PremiumJan 17, 2025Expiry Date3.47Intrinsic Value100Multiplier24DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9298Delta0.0983Gamma1.15Leverage Ratio-0.0037Theta-0.0027Rho-1.07Eff Leverage0.0014Vega
COMPASS Pathways Stock Discussion
https://www.fda.gov/news-events/press-announcements/fda-issues-first-draft-guidance-clinical-trials-psychedelic-drugs
NEWS
Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 study of COMP360 psilocybin in post-traumatic stress disorder
NEWS
Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the development of a scalable and cost-effective delivery model for investigational COMP360 psilocybin treatment
• $Genco Shipping & Trading (GNK.US)$ +4.7% (positive Barrons article)
• $NextDecade (NEXT.US)$ +4.7% (files for 4618226 share common stock offering by selling shareholder)
• $COMPASS Pathways (CMPS.US)$ +4.7% (COMPASS Pathways presents largest ever study of psilocybin therapy at American Psychiatric Association annual meeting)
• $Canoo (GOEV.US)$ +3.5% (files for 48043111 share common stock offering by selling shareholder)
• $American Axle & Mfg (AXL.US)$ +3.7% (pr...
$Cybin (CYBN.US)$ $Enveric Biosciences (ENVB.US)$ $Mind Medicine (MNMD.US)$ $Seelos Therapeutics (SEEL.US)$ $COMPASS Pathways (CMPS.US)$ $ADVISORSHARES PSYCHEDELICS ETF (PSIL.US)$ building up short positions. The whole sector has taken a huge smack regardless of the fda approvels, Cybin having a clinic in New York. Envb having its Psy-ai. Seelos is up big without any indication of why. Mind med is down, started more studies on mdma and lsd. Get ready and load up. Things are looking strange.
Since early 2020, the industry for medicinal psychedelic drugs received an extraordinary injection of capital, launching several companies in major exchanges like the NYSE and the Nasdaq, some of which now have valuations of over $1 billion.
Psychedelics Companies Listed On The Nasdaq And NYSE
Atai Life Sciences ( $ATAI Life Sciences (ATAI.US)$ )
Compass Pathways ( $COMPASS Pathways (CMPS.US)$ )
MindMed ( $Mind Medicine (MNMD.US)$ )
Field Trip Health, Inc. ( $Field Trip Health (FTRP.US)$ )
Seelos Therapeutics ( $Seelos Therapeutics (SEEL.US)$
Enveric Biosciences ( $Enveric Biosciences (ENVB.US)$ )
Pasithea Therapeutics Corp. ( $Pasithea Therapeutics (KTTA.US)$ )
GH Research ( $Coherus BioSciences (CHRS.US)$ )
Cybin Corp ( $Cybin (CYBN.US)$ )
No comment yet